Dr Reddy's recalls contaminated simvastatin in the US
This article was originally published in Scrip
Executive Summary
Dr Reddy's Laboratories has initiated a recall of certain strengths of its cholesterol-lowering drug, simvastatin, in the US following concerns over 'chemical contamination' of the product.